Apheresis Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Apheresis Market Research and Forecast
Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• IMARC Group is a global management consulting
  firm that helps the worlds most ambitious
  changemakers to create a lasting impact. Across
  the six major continents and 100 countries, we
  work alongside our business partners as one team
  with a common ambition to achieve unparalleled
  results, gain a competitive edge, and transform
  industries. IMARC Group excels in understanding
  its clients business priorities and delivering
  tailored solutions that drive meaningful
  outcomes. Our client base spans over 3,000
  organizations in the private, public, and social
  sectors, ranging from high-growth startups to
  Fortune 500 companies.
• We provide a comprehensive suite of market entry
  and expansion services. Our offerings include
  thorough market assessment, feasibility studies,
  company incorporation assistance, factory setup
  support, regulatory approvals and licensing
  navigation, branding, marketing and sales
  strategies, competitive landscape and
  benchmarking analyses, pricing and cost research,
  and procurement research. These services are
  designed to assist companies in evaluating market
  opportunities, setting up new entities,
  navigating regulatory landscapes, boosting brand
  visibility, analyzing competitors, and optimizing
  procurement strategies.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Apheresis Market Global Industry Trends,
  Share, Size, Growth, Opportunity and Forecast
  2024-2032," the global apheresis market size
  reached US 2.9 Billion in 2023.
• Factors Affecting the Growth of the Apheresis
  Industry
• Increasing Prevalence of Chronic Diseases
• Chronic diseases, such as cancer, autoimmune
  disorders, and blood-related conditions, often
  require therapeutic interventions that involve
  removing harmful components from the blood.
  Apheresis procedures enable the selective removal
  of these components, thereby helping to manage
  the symptoms and progression of these diseases.
• Apheresis techniques are also used for diagnostic
  purposes in various chronic diseases. Apheresis
  can also help in analyzing specific blood
  components or identifying biomarkers associated
  with certain conditions, aiding in disease
  diagnosis and monitoring.
• Technological Advancements
• Innovations in apheresis technology are leading
  to the development of more efficient systems for
  blood component separation. These advancements
  enable higher throughput, shorter procedure
  times, and increased collection yields, enhancing
  the overall efficiency of apheresis procedures.

4
Report Highlight and Description

• Modern apheresis machines incorporate
  sophisticated automation and control features
  that allow for precise manipulation of blood
  components. This precision ensures the accurate
  separation and collection of specific blood
  components, minimizing the risk of procedural
  errors and improving patient outcomes.
• Growing Demand for Blood Components
• Apheresis procedures enable the selective
  collection of specific blood components, such as
  platelets, plasma, and white blood cells (WBCs).
  These components have diverse therapeutic
  applications in transfusion medicine, hematology,
  oncology, and immunology.
• Platelets play a crucial role in hemostasis and
  are frequently needed for patients with bleeding
  disorders, undergoing surgery, or receiving
  chemotherapy. Apheresis allows for the efficient
  collection of platelets from single donors,
  meeting the high demand for these blood products.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/apheresis-market/reques
  tsample

5
Report Description

• Global Apheresis Market Trends
• There is a growing emphasis on personalized or
  precision medicine approaches, which require
  tailored blood component therapies collected
  through apheresis procedures to meet individual
  patient needs. Apheresis procedures are finding
  expanding therapeutic applications beyond
  traditional uses, including the treatment of
  neurological disorders, organ transplantation,
  and immune-mediated diseases, driving market
  diversification.
• Rising awareness among healthcare professionals
  and patients about the benefits of apheresis
  procedures is leading to higher acceptance and
  utilization of these techniques, contributing to
  the market growth.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/apheresis-market

6
Report Segmentation

• Breakup by Component
• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or Leukopheresis)
• Lymphocytes (Lymphopheresis or Lymphapheresis)
• RBC's (Erythropheresis)
• Breakup by Product
• Devices
• Disposables and Reagents
• Software
• Breakup by Technology
• Centrifugation

7
Report Segmentation

• Membrane Separation
• Selective Adsorption
• Breakup by Procedure
• Donor/Automated Apheresis
• Therapeutic Apheresis
• Breakup by Application
• Renal Disorders
• Hematological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

8
Report Segmentation

• Breakup by End User
• Blood Centers
• Hospitals
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

9
Competitive Landscape with Key Players

• Asahi Kasei Medical Co. Ltd. (Asahi Kasei
  Corporation)
• B. Braun SE
• Charles River Laboratories International Inc.
• Fresenius Medical Care AG Co. KGaA
• Haemonetics Corporation
• Haier Biomedical
• Kaneka Corporation
• Medica S.p.a.
• Miltenyi Biotec
• Nikkiso Co. Ltd.
• Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite
  Company Limited)
• Terumo Bct Inc. (Terumo Corporation).

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Apheresis Market   
  5.1    Market Overview    5.2    Market
  Performance    5.3    Impact of COVID-19  5.4
     Market Forecast
• 6     Market Breakup by Component
• 6.1 Plasma (Plasmapheresis)
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Platelets (Plateletpheresis)
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Leukocytes (Leukapheresis or
  Leukopheresis)
• 6.3.1 Market Trends
• 6.3.2 Market Forecast       

13
Table of Contents

• 6.4 Lymphocytes (Lymphopheresis or
  Lymphapheresis)
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 6.5 RBC's (Erythropheresis)
• 6.5.1 Market Trends
• 6.5.2 Market Forecast
• 7 Market Breakup by Product
• 7.1 Devices
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Disposables and Reagents
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Software
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 8 Market Breakup by Technology
• 8.1 Centrifugation
• 8.1.1 Market Trends

14
Partial List of Clients
15
Partial List of Clients
16
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

17
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us